So you admit that <<I am not qualified to make an objective analysis of Iclusig adverse events. >>
I can affirm that the oncologist investigators of the Iclusig follow up trials are QUALIFIED. Take a look at the papers they are presenting at ASH conf in December. The abstracts are posted.
Do you or jq1234 have any thoughts on why the conclusions drawn by the above oncologists are diametrically opposite to the negative conclusions of the FDA????
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.